Latest Production Development News

Amotiv Limited reported modest revenue growth and a slight EBITA decline in FY25, offset by a significant non-cash impairment and strong capital returns. The company anticipates growth in FY26 amid ongoing market headwinds.

Oneview Healthcare reported a robust 36% revenue increase in H1 2025, driven by US market growth and the launch of its AI-powered Care Assistant, Ovie. Operational restructuring and AI innovation underpin its strategy for scalable, efficient deployments.

Amotiv Limited reported a modest 1% revenue increase for FY25 alongside a significant $190 million impairment, maintaining shareholder returns with a stable dividend. The company signals cautious optimism for FY26 despite ongoing market headwinds.

Audeara Limited has secured a five-year licensing agreement with Eastech (Huizhou) Co., Ltd. to bring its advanced hearing technology to China’s booming medical device market, leveraging major e-commerce platforms for distribution.

WhiteHawk Limited has completed the first tranche of its capital raising, issuing over 135 million shares and raising A$1.56 million, with a second tranche pending shareholder approval in September.

RooLife Group Ltd has successfully raised $2 million through an oversubscribed strategic placement, positioning the company to expand its e-commerce footprint across key international markets.

Minbos Resources has partnered exclusively with Fertiafrica to produce Angola’s first locally granulated fertilisers, aiming to transform the country’s agricultural landscape with affordable, high-quality products.

FBR Limited has raised A$2 million through a share placement and purchase plan, complementing a $20 million subscription facility, to fund new robotic products, strategic partnerships, and debt repayment.

Nutritional Growth Solutions Ltd (NGS) has had its trading suspension lifted following a key announcement about a capital raising, signaling renewed market activity.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Zoono Group Limited has closed its recent rights issue, raising $785,000 with a significant shortfall remaining. Managing Director Paul Hyslop fully subscribed and may provide further financial support as the company targets growth in Asia and product innovation.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.